Nkarta, Inc.

Nkarta, Inc. - Enterprise Valueverified

NKTX

Price:

$2.86

Market Cap:

$204.62M

Nkarta, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to advancing and marketing cell-based treatments for cancer. Their innovative cellular immunotherapy strategy outfits natural killer (NK) cells with chimeric antigen receptors (CARs) on their surface, allowing these cells to pinpoint particular proteins or antigens found on the exterior of tumor cells. The company's primary investigational products include NKX101, which is undergoing Phase I human trials for resistant or recurring acute myeloid leukemia and high-risk myelodysplastic syndromes. Another key candidate is NKX019, a pre-clinical asset designed to combat various B-cell malignancies by targeting the...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

NASDAQ

Ticker

NKTX

The Enterprise Value as of June 2026 (TTM) for Nkarta, Inc. (NKTX) is 252.26M

According to Nkarta, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 252.26M. This represents a change of 45.03% compared to the average of 173.94M of the last 4 quarters.

Nkarta, Inc. (NKTX) Historical Enterprise Value (quarterly & annually)

How has NKTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Nkarta, Inc. over the last ten years is 779.40M. The current 252.26M Enterprise Value has changed 3.14% with respect to the historical average. Over the past ten years (40 quarters), NKTX's Enterprise Value was at its highest in in the December 2020 quarter at 1.92B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

779.40M

Median

398.89M

Minimum

173.67M

Maximum

2.41B

Nkarta, Inc. (NKTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nkarta, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 347.68%

Maximum Annual Enterprise Value = 2.41B

Minimum Annual Increase = -82.72%

Minimum Annual Enterprise Value = 173.67M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025173.67M-21.55%
2024221.38M-41.86%
2023380.79M24.12%
2022306.79M-32.72%
2021456.00M-75.57%
20201.87B347.68%
2019416.99M-82.72%

Nkarta, Inc. (NKTX) Average Enterprise Value

How has NKTX Enterprise Value performed in the past?

The current Enterprise Value of Nkarta, Inc. (NKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

258.62M

5-year avg

307.73M

10-year avg

779.40M

Nkarta, Inc. (NKTX) Enterprise Value vs. Peers

How is NKTX’s Enterprise Value compared to its peers?

Nkarta, Inc.’s Enterprise Value is greater than Alector, Inc. (151.88M), greater than PepGen Inc. (98.22M), less than Fate Therapeutics, Inc. (280.82M), greater than Molecular Partners AG (40.49M), greater than Cassava Sciences, Inc. (-27637367.00), greater than Applied Therapeutics, Inc. (5.42M), greater than Cybin Inc. (-84061835.96), greater than Elicio Therapeutics, Inc. (72.87M), greater than Vor Biopharma Inc. (-67620902.00), greater than Forte Biosciences, Inc. (189.64M),

CompanyEnterprise ValueMarket cap
151.88M$194.29M
98.22M$123.81M
280.82M$243.61M
40.49M$143.29M
-27637367.00$63.77M
5.42M$14.86M
-84061835.96$413.02M
72.87M$73.48M
-67620902.00$99.31M
189.64M$247.86M

Build a custom stock screener for Nkarta, Inc. (NKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nkarta, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nkarta, Inc. (NKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nkarta, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nkarta, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Nkarta, Inc. (NKTX)?

What is the 3-year average Enterprise Value for Nkarta, Inc. (NKTX)?

What is the 5-year average Enterprise Value for Nkarta, Inc. (NKTX)?

How does the current Enterprise Value for Nkarta, Inc. (NKTX) compare to its historical average?